AND019·MSA

N/A

Report date: 2024/01/12 13:53:39
NME

Base Information

Drug NameAND019·MSA
Drug Alias NameAND019·MSA胶囊AND019·MSA
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEstrogen receptors antagonists
TargetsEstrogen receptors
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesHangzhou Andao Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesHangzhou Andao Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A